I am aware that other publications on microRNAs as neurorestorative therapy for ischemic stroke have been published, but this article updates and completes the concepts previously reported in the literature.
The pathogenetic and therapeutic strategy of miRNAs in neuroinflammation and cytokine generation should be expanded. The section relating to the inflammatory cytokines should also be amplified as they are very important and today are quoted in a high percentage of publications. For this reason the following papers should be read and incorporated into the manuscript and reported in the reference section.
